HTT
HTT encodes the huntingtin protein, a versatile scaffold critical for neuronal survival, axonal transport, and autophagic clearance. Expansion of a CAG trinucleotide repeat in this gene causes Huntington disease through both a loss of neurotrophic support and a toxic gain-of-function from misfolded protein aggregates.
Key Takeaways
- •HTT is a scaffolding protein essential for neuronal development, axonal transport, and cellular clearance.
- •Mutation of HTT via CAG repeat expansion causes Huntington’s disease (HD), leading to severe neurodegeneration.
- •Wild-type HTT promotes the production and transport of BDNF, a critical factor for brain health and survival.
- •Pathogenesis involves both a loss of normal function and the gain of toxic effects from aggregated mutant protein.
Basic Information
- Gene Symbol
- HTT
- Full Name
- Huntingtin
- Also Known As
- HDIT15
- Location
- 4p16.3
- Protein Type
- Scaffolding Protein
- Protein Family
- Huntingtin Family
Related Isoforms
Key SNPs
Common marker frequently targeted in allele-specific antisense oligonucleotide (ASO) therapy research.
Exon 67 variant used to distinguish wild-type from mutant alleles in gene-silencing approaches.
Genomic marker used in haplotype analysis and association studies for HD age of onset.
Studied as a potential modifier of disease progression and phenotypic variability.
Part of common HTT haplotypes used for ancestral tracing and therapeutic targeting.
Associated with differential mRNA expression levels and clinical outcomes in HD.
Coding variant frequently used in clinical research for allele-specific silencing.
Overview
HTT encodes the huntingtin protein, a massive and versatile scaffold that is critical for the survival of neurons. It is involved in a wide array of cellular processes, including chemical signaling, transporting materials, attaching to proteins and structures, and protecting cells from self-destruction. Its most famous role is in Huntington’s disease, where an expansion of a CAG trinucleotide repeat leads to a toxic gain-of-function.
In its healthy state, HTT helps coordinate the transport of neurotrophic factors and autophagic vesicles along the long axons of neurons. When mutated, the protein misfolds and aggregates, disrupting these transport pathways and triggering cellular stress.
Conceptual Model
A simplified mental model for the pathway:
HTT is required for life; its mutation transforms a vital cellular scaffold into a toxic agent.
Core Health Impacts
- • Striatal survival: Maintains striatal and cortical neuron health.
- • BDNF delivery: Ensures delivery of BDNF to target tissues.
- • Autophagic clearance: Facilitates autophagic clearance of misfolded proteins.
- • Transcriptional control: Regulates transcriptional programs for neuronal identity.
- • Energy stabilization: Protects mitochondria and stabilizes energy metabolism.
Protein Domains
N-terminal (PolyQ)
Contains the polyglutamine tract. Expansion beyond ~36 repeats causes misfolding and aggregation.
HEAT Repeats
Modular motifs that facilitate protein-protein interactions, acting as a versatile scaffold.
C-terminal
Involved in regulating protein stability and interaction with autophagic machinery.
Upstream Regulators
BDNF Activator
Promotes wild-type HTT stability and survival signaling in neurons.
CREB Activator
Transcriptional regulator that drives expression of neurotrophic factors with HTT.
IGF-1 Activator
Triggers HTT phosphorylation at Ser421 to enhance pro-survival functions.
REST/NRSF Inhibitor
Wild-type HTT sequesters this repressor in the cytoplasm.
Dynein/Kinesin Activator
Molecular motors that HTT scaffolds for axonal transport.
ULK1 Activator
Interacts with HTT to initiate autophagosome formation.
Downstream Targets
BDNF Activates
Wild-type HTT promotes the synthesis and axonal transport of this trophic factor.
Vesicle transport Activates
Regulates movement of synaptic vesicles and mitochondria along axons.
Autophagosomes Activates
HTT acts as a scaffold for autophagic machinery maturation.
Synaptic plasticity Activates
Influences neurotransmitter release and dendritic spine maintenance.
REST target genes Activates
By sequestering REST, HTT maintains neuronal gene expression.
Mitochondrial motility Activates
Works with HAP1 to regulate mitochondrial trafficking.
Role in Aging
HTT is a key player in the cellular quality control network. Its interaction with autophagy regulators and molecular motors makes it a central component of how cells manage the accumulation of damaged proteins and organelles over time.
Autophagic flux
Wild-type HTT supports the formation and movement of autophagosomes. As cells age, the efficiency of this system declines; in HD, mutant HTT further impairs cargo loading.
Proteotoxicity
The accumulation of mutant HTT aggregates is a hallmark of HD. These aggregates can sequester other essential proteins, leading to a broader collapse of cellular proteostasis.
Neurotrophic support
The delivery of BDNF to the striatum is a maintenance program that naturally wanes with age. HTT mutation causes an early and severe breakdown of this transport.
Mitochondrial aging
Mutant HTT disrupts mitochondrial trafficking and dynamics. This leads to energy deficits and increased oxidative stress, mimicking aging-related dysfunction.
Epigenetic clocks
Mutant HTT has been shown to alter DNA methylation patterns, potentially accelerating the "biological age" of affected tissues.
Longevity signaling
HTT signaling interacts with the IGF-1 and SIRT1 axes. Balanced signaling supports neuronal resilience, while the HD state interferes with these pathways.
Disorders & Diseases
Huntington’s Disease (HD)
An autosomal dominant neurodegenerative disorder characterized by chorea, cognitive decline, and psychiatric symptoms.
Juvenile HD
Associated with very large CAG expansions (>60). Features include stiffness and rapid progression.
Neurodevelopmental Defects
Complete loss of HTT is embryonic lethal. Subtle variations are studied for impact on brain connectivity.
Metabolic Dysfunction
HD patients often exhibit weight loss and muscle wasting, indicating HTT’s role in energy regulation.
Cerebral Amyloid Angiopathy
Mutant HTT can intersect with other proteinopathies, although primarily distinct.
Interventions
Supplements
Polyphenol studied for its potential to induce autophagy and reduce mutant HTT aggregation.
Investigated for neuroprotective effects and mitochondrial energy support.
Mitochondrial antioxidant studied in clinical trials for slowing disease progression in HD.
May support membrane integrity and provide modest anti-inflammatory benefits.
Studied for antioxidant properties and regulating circadian rhythms disrupted in HD.
Lifestyle
Increases endogenous BDNF levels, potentially delaying symptom onset.
Cognitive and social stimulation may enhance synaptic resilience.
Critical for glymphatic clearance and proteostasis; sleep loss exacerbates neurodegeneration.
Programs help maintain mobility, balance, and coordination during progression.
Medicines
VMAT2 inhibitor used for the management of chorea; depletes presynaptic dopamine.
Highly selective VMAT2 inhibitor approved for chorea associated with HD.
Antipsychotic sometimes used to manage irritability or psychosis in HD patients.
Antisense oligonucleotides in trials designed to reduce total or mutant HTT protein levels.
Lab Tests & Biomarkers
Genetic Testing
The definitive diagnostic test for HD. Measures CAG repeats in exon 1.
For at-risk individuals without symptoms; requires rigorous counseling.
Disease Biomarkers
Elevated marker for active neuroaxonal damage in blood and CSF.
Direct measurement of toxic protein; used to assess target engagement.
Functional Markers
Standardized clinical scale for assessing motor impairment in HD.
Imaging biomarker used to track structural brain atrophy over time.
Hormonal Interactions
Estrogen Neuroprotector
Reported to have protective effects on striatal neurons.
IGF-1 Survival Factor
Promotes HTT phosphorylation at Ser421, a key modification for survival.
BDNF Trophic Feedback
Acts both upstream to stabilize HTT and downstream as a product.
Cortisol Stress Modulator
Chronic stress-induced elevation can exacerbate neurodegeneration.
Growth Hormone Indirect Trophic
Elevates IGF-1 levels, supporting neuronal resilience.
Melatonin Circadian Lead
Studied for sleep and neuroprotection; deficiencies are common in HD.
Deep Dive
Network Diagrams
HTT Axonal Scaffold Network
The HTT-REST-BDNF Survival Circuit
The Scaffolding Logic: HTT as a Multi-Tool for Axons
Huntingtin is one of the largest proteins in the human proteome, and its primary function is to act as a physical organizer. It contains dozens of HEAT repeats—motifs that resemble a deck of cards stacked at an angle, providing a vast surface area for other proteins to bind.
Axonal logistics: In neurons, materials must travel vast distances from the cell body to the synapse. HTT acts as a bridge between vesicles (carrying BDNF or mitochondria) and the molecular motors (dynein and kinesin) that pull them along microtubule tracks.
Autophagic scaffolding: HTT doesn’t just move things; it helps decide what to throw away. It interacts with the autophagy machinery to recognize damaged organelles and ensures they are correctly packaged into autophagosomes for degradation.
The HD glitch: When the PolyQ tract is expanded, the entire HTT “multi-tool” becomes sticky and rigid. It fails to bind its cargo efficiently and instead gums up the works, creating traffic jams in the axon and leaving toxic debris uncollected.
The HTT-REST-BDNF Circuit: A Survival Loop
One of the most critical roles of wild-type HTT is the regulation of Brain-Derived Neurotrophic Factor (BDNF), the “fertilizer” of the brain.
Transcriptional control: In healthy neurons, HTT sequesters the repressor protein REST (also known as NRSF) in the cytoplasm. This keeps REST away from the BDNF gene in the nucleus, allowing for robust BDNF production.
Feedback breakdown: In HD, mutant HTT loses its grip on REST. REST enters the nucleus and shuts down the BDNF gene. At the same time, mutant HTT impairs the transport of whatever little BDNF is produced. The result is a “double hit” of neurotrophic deprivation.
Therapeutic logic: This circuit explains why increasing BDNF or restoring HTT’s ability to sequester REST are major areas of research for delaying disease progression.
Pathogenic Thresholds: The CAG Counting Game
Huntington’s disease is unique because its severity is governed by a precise trinucleotide count.
<26 Repeats: Normal range. No disease risk.
27-35 Repeats: Intermediate range. The individual will not develop HD, but the repeat may expand in their offspring (especially through the paternal line).
36-39 Repeats: Reduced penetrance. Some individuals develop symptoms late in life, while others remain asymptomatic.
40+ Repeats: Full penetrance. Almost all individuals will develop symptoms if they live a normal lifespan. Expansions >60 lead to Juvenile HD.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
The landmark study that identified the HTT gene and the CAG repeat expansion.
Established that wild-type HTT is required for BDNF transcription.
Demonstrated that HTT acts as a scaffold for the axonal transport of BDNF vesicles.
Showed that mutant HTT interferes with autophagosome clearance.